Article
High Mobility Group A1 Is a Molecular Target for MYCN in Human Neuroblastoma
15 Sept 2005
Abstract excerpt
High mobility group A1 (HMGA1) is an architectural transcription factor and a putative protoncogene. Deregulation of its expression has been shown in most human cancers. We have previously shown that the expression of the HMGA family members is deregulated in neuroblastoma cell lines and primary tumors. On retinoic acid (RA) treatment of MYCN-amplified neuroblastoma cell lines, HMGA1 decreases with a kinetics...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
